Putnam Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-42,632
| Closed | -$300K | – | 1145 |
|
|
2023
Q2 | $300K | Buy |
42,632
+3,153
| +8% | +$22.2K | ﹤0.01% | 1083 |
|
|
2023
Q1 | $329K | Sell |
39,479
-1,654
| -4% | -$13.8K | ﹤0.01% | 1068 |
|
|
2022
Q4 | $472K | Sell |
41,133
-22
| -0.1% | -$253 | ﹤0.01% | 941 |
|
|
2022
Q3 | $518K | Sell |
41,155
-748
| -2% | -$9.42K | ﹤0.01% | 933 |
|
|
2022
Q2 | $443K | Sell |
41,903
-518
| -1% | -$5.48K | ﹤0.01% | 968 |
|
|
2022
Q1 | $690K | Sell |
42,421
-3,025
| -7% | -$49.2K | ﹤0.01% | 941 |
|
|
2021
Q4 | $629K | Buy |
+45,446
| New | +$629K | ﹤0.01% | 916 |
|
|
2016
Q1 | – | Sell |
-199,100
| Closed | -$2.06M | – | 1405 |
|
|
2015
Q4 | $2.06M | Hold |
199,100
| – | – | ﹤0.01% | 967 |
|
|
2015
Q3 | $2.27M | Hold |
199,100
| – | – | 0.01% | 953 |
|
|
2015
Q2 | $2.97M | Sell |
199,100
-2,130
| -1% | -$31.8K | 0.01% | 926 |
|
|
2015
Q1 | $1.82M | Buy |
+201,230
| New | +$1.82M | ﹤0.01% | 1074 |
|